SEC 13F Intelligence

Yong Rong (Hk) Asset Management Ltd / REGN

Yong Rong (Hk) Asset Management Ltd’s Regeneron Pharmaceuticals Position

Does Yong Rong (Hk) Asset Management Ltd own Regeneron Pharmaceuticals (REGN)? Not currently — the last reported position was 10.0K shares worth $3M in Q3 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$3M
Q3 2019
Shares
10.0K
% of Portfolio
+3.40%
Quarters Held
2
position exited

Position History REGN

Reported value by quarter
Q2 ’19: $3MQ2 ’19Q3 ’19: $3MQ3 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q3 201910.0K$3M+3.40%
Q2 201910.0K$3M+4.51%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Yong Rong (Hk) Asset Management Ltd’s full portfolio or all institutional holders of REGN.